Widmann Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Widmann Financial Services's BMY Position: Q2 2026 in Review
Widmann Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, selling an estimated $62.3K and leaving 7,881 shares worth $454K. The position accounts for 0.24% of the portfolio, ranked #82.
Widmann Financial Services first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $661K in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Widmann Financial Services held 7,881 shares of Bristol-Myers Squibb worth $454K as of Q2 2026.
- Widmann Financial Services sold 1,085 Bristol-Myers Squibb shares in Q2 2026, an estimated $62.3K.
- Bristol-Myers Squibb made up 0.24% of Widmann Financial Services's portfolio in Q2 2026, its #82 holding.
- Widmann Financial Services first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Widmann Financial Services's Bristol-Myers Squibb position peaked at $661K in Q2 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Widmann Financial Services's 13F filing for Q2 2026, filed 14 Aug 2026.